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Homologous and heterologous complexes between catalytic and GTP-binding components can be isolated 
by means of immobilized succinyldeacetylforskolin (forskolin-Sepharose). A heterologous complex is 
formed by reconstitution of forskolin-Sepharose bound catalytic function from rabbit myocardial 
membranes with the homogeneous [3H]methyl-GTP-binding protein from duck erythrocyte membranes. 
Analysis of the reconstituted complex by sodium dodecyl sulfate polyacrylamide gelelectrophoresis reveals 
that only the M, 42000 component of the GTP-binding protein’s M, 42000/M, 35 000 heterodimer 
contributes to the formation of active adenylate cyclase. 
Adenylate cyclase Forskolin G-protein 
1. INTRODUCTION 
It is now clear that the hormonally regulated 
adenylate cyclase of higher cells is made up of 
several distinct polypeptides: hormone receptors 
for stimulating or inhibitory hormones, regulatory 
GTP-binding protein(s) mediating the action of 
stimulatory or inhibitory hormones and a catalytic 
protein as a signal receiver generating CAMP [l-6], 
Recently, some of these components have been 
purified to apparent homogeneity: the,&adrenergic 
receptor [7,8] and the GTP-binding component 
(G-protein, Ns or G/F) [9- 111. The latter has been 
shown to consist of either 55, 45, 35 kDa or 42, 
35 kDa subunits [9-l 11. There is evidence that the 
active species of adenylate cyclase represents a 
[G * C] complex: using [ 32P]ADP-ribosylated G- 
protein, partially purified from pigeon erythrocyte 
membranes, we have observed that the radiolabeled 
42 kDa subunit was sedimenting together with the 
Abbreviations: Gpp(NH)p, guanosine U@,y-imino)tri- 
phosphate; GTPyS, guanosine 5 ’ -(3_thiotriphosphate); 
Mops, 3-(N-morpholino)propanesulfonic acid 
Reconstitution Guanine nucleotide 
formed holoenzyme [3]. However, we could not 
decide whether only the 42 kDa component or the 
35 kDa subunit as well was involved. Two lines of 
evidence have been presented that only the larger 
entity was forming the activated complex together 
with C. First, it has been observed that the size of 
the regulatory G-protein is apparently reduced 
when it is activated by GTPyS or fluoride [3,12]. 
Second, it has been shown recently that excess 
35 kDa subunit inhibits the rate and extent of re- 
constitution by the G-protein in the presence of 
GTPyS [12]. This has been interpreted to mean 
that following binding of the nucleotide dissoci- 
ation of the 42 kDa/35 kDa dimer precedes forma- 
tion of the active [G*C] complex. Purification of 
some of the components of the adenylate cyclase 
complex has been considerably facilitated by the 
use of suitable ligands for affinity labeling and 
affinity chromatography [2,12,13]. 
Such a specific ligand also seems to be available 
now for the catalytic portion of the enzyme since 
the discovery by Metzger and Lindner [14] and by 
Daly’s group [15] that the hypotensive plant con- 
stituent forskolin activates adenylate cyclase from 
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a variety of sources obviously through bypassing 
the hormone receptor and the activating G-protein. 
We have introduced forskolin-Sepharose as a 
powerful tool for purification adenylate cyclase 
and have presented evidence that the catalytic por- 
tion rather than the G-protein is recognized by the 
diterpene [16]. 
2. MATERIALS AND METHODS 
2.1. ~ffteria~s 
ATP, GPP(NH)p, GTP+, creatine phos- 
phate and creatine kinase were purchased from 
Boehringer (Mannheim). Carbonyldiimidazole, 
DL-isoproterenol and Tween 60 were obtained 
from Serva (Heidelberg). Tween 60 was deionized 
by passage through a mixed bed ion exchanger 
(AG 501 x 8; BioRad, Munich). Lubrol PX, beef 
heart lactate dehydrogenase, pig heart malate de- 
hydrogenase and cytochrome c (horse heart) were 
from Sigma (Munich). Ultrogel ACA 34 was a 
product from LKB; DEAE-Sephacel, Sepharose 
CL-4B and Sephadex G-25 were purchased from 
Pharmacia (Uppsala). Heptylamine-Seph~ose CL- 
4B was prepared as in 1181. For swelling of poly- 
acrylamide gel slices Tissue solubilizer TS 1 from 
Zinsser was used. [a-32P]ATP (lo-30 Ci/mmol) 
and [35S]GTPyS (SSOCi/mmol) were from New 
England Nuclear (Dreieich), c[~H]AMP (15-30 Ci/ 
mmol), NaB3H4 (12.4 Ci/mmol) and l-fluoro- 
2,4-dinitro[3,5-3H]benzene (lo-30Ci/mmol) were 
from the Radiochemical Centre (Amersham). All 
other chemicals were of the highest purity available. 
Doubly distilled water was used throughout. Pro- 
tein was determined as in 1191 or, with fluoro- 
dinitrot3H]benzene as in 1201. Soluble adenylate 
cyclase from cardiac muscle of New Zealand rabbits 
was prepared as in [16] using 5 mM Lubrol PX, 
10mM Mops, 1 mM Mg2+/EDTA (pH 7.4) and 
membrane protein at lOmg/ml. The Lubrol ex- 
tract was centrifuged at 100000 x g for 60 min. A 
floating turbid layer was discarded and the clear 
supernatant saved. Adenylate cyclase assays in the 
presence of 0.1 mM ATP, unless otherwise stated, 
were performed at 30°C for 10 min as in 1161. 
CAMP production was linear with time for at least 
20 min. Forskolin was added to the assay mixtures 
as concentrated ethanolic solution. Control samples 
also received ethanol at 1% final concentration. 
2.2. Preparation o~acti~ated G-protein from duck 
erythrocyte membranes 
2.2.1. Membranes 
Erythrocytes were collected from the blood of 
ducks (either sex) obtained from a local slaughter- 
house. Plasma membranes were prepared as in [21] 
with minor modifications described in [22]. They 
were stored in 20mM phosphate buffer (pH 7.4), 
containing 3 mM MgCl2, 1 mM EDTA, 150 mM 
NaCl at -70°C. 
2.2.2. Activation of G-protein and purification 
procedure 
2.5 g of plasma membranes in 250 ml of buffer 
described above, were incubated with 20pM Gpp- 
(NH)p and 1OOpM DL-isoproterenol for 20 min at 
37°C. The membranes were spun down at 15000 
rpm for 20 min in an SS 34 rotor (Sorvall) and suc- 
cessively washed with 250ml each of buffer A 
[20 mM Tris-HCI (pH 8.0), 1 mM EDTA, 1 mM 
DTE] plus 5OOmM NaCl, buffer A and buffer A 
containing 50mM NaCl. Membr~es were sus- 
pended in 250ml of buffer A adjusted to 50mM 
NaCl and 2.5% cholate. The suspension was stir- 
red at 4’C for 60min and nonsolubilized material 
separated by centrifugation at 100000 x g for 
60 min. The supernatant was diluted with buffer B 
(buffer A plus 1 mM ATP, 6 mM MgCl2, 10 mM 
NaF) to yield a cholate concentration of 1% and 
was applied on top of a DEAE-Sephacel column 
(2.5 x 51 cm) which has been equilibrated with 
buffer B containing 1% cholate. The following 3 
purification steps, DEAE-Sephacel, Ultrogel ACA 
gelfiltration, heptylamine-Seph~ose chromato- 
graphy, were essentially identical to those reported 
for the purification of hepatic G-protein 19, lo]. In 
contrast to various other purification steps re- 
ported by these authors a sucrose density gradient 
centrifugation step was found to be most con- 
venient, achieving more than 95% purity of the 
erythrocyte G-protein: The pooled eluates from the 
heptylamine Sepharose chromatography (10 ml) 
were diluted to 20 ml with buffer C [ 10 mM Mops 
(pH 7.4), I mM MgClt 1 mM EDTA] and concen- 
trated to 2 ml in an Amicon CF-25 centrifilo filter 
cone device. One ml each of the concentrate was 
layered on top of a linear 5-2070 sucrose gradient 
(38 ml, in buffer C containing 1 mM Lubrol PX) 
and centrifuged in a VT1 50 (Beckman) vertical 
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rotor for 14 h at 42000 rpm (4°C). Fractions of 
1.3 ml were obtained by puncturing the bottom of 
the tubes and tested for reconstitutive adenylate 
cyclase activity. The maximum of activity ap- 
peared in fractions 8-9. Only those fractions were 
pooled which were devoid of excessive 35 kDa 
component and concentrated to about 200~1 in an 
Amicon CF-25 filter cone. The G-protein was 
stored at a concentration of about 5OOpg/ml in the 
presence of 15% glycerol at -70°C. Reconstitutive 
activity of G-protein-containing fractions was rou- 
tinely measured by combination with a crude non- 
activated adenylate cyclase preparation sulubilized 
from duck erythrocyte membranes (3Opg protein 
per assay). These were solubilized as in [23] using 
5 mM Lubrol PX and a membrane concentration 
of 10 mg/ml. The fluoride concentration in the col- 
umn eluates was diluted to <0.5 mM in the cyclase 
assay. Occasionally, fluoride (and cholate) in the 
fractions was removed by centrifugation through 
2 ml of dehydrated Sephadex G-25 fine in buffer C 
containing 100 mM NaCl and 1 mM Lubrol PX. 
Considerably higher reconstitutive activity could 
be obtained by combination of G-protein with the 
catalytic portion of particulate membrane prepara- 
tions (1OOpg membrane protein per assay) from 
rabbit myocardium. In this case specific reconsti- 
tutive activity of the finally purified G-protein 
varied between 3 and 6~mol~mg-‘~min-’ at 30°C 
using 1 mM Mg’+/ATP as substrate. 
2.3. Reductive methylation of duck erythrocyte 
G-protein 
The procedure was adopted from [25] for the 
radiolabeling of ribosomal proteins. Briefly, 2~1 of 
an aqueous solution of formaldehyde (1%) were 
added to 45~1 of pure G-protein (210pg/ml) in 
100 mM borate buffer (pH 8.5), 1 mM Tween 60 in 
an Eppendorf tube at 0°C. Following addition of 
about 10 mCi NaB3H4 (solid) the reaction was left 
for 3 min at 0°C. Subsequently, 5 l-p1 aliquots of 
aqueous formaldehyde (1 (r/o) were supplied every 
2 min. In order to ensure completeness of reduc- 
tion, 4~1 of a solution of unlabeled NaBH4 
(3 mg/ml) were added and left for another 3 min at 
0°C. Excess borohydride (and methanol) was re- 
moved by centrifuging of the mixture in a plastic 
syringe through 1 ml of dehydrated Sephadex G-25 
fine in buffer D (buffer C plus 1 mM Tween 60, 
50mM NaCl). The eluate containing [3H]methyl- 
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G-protein (0.825rWpg) was quickly frozen to- 
gether with 15% glycerol in liquid nitrogen. On 
storage at -70°C no measurable decay of reconsti- 
tutive activity could be observed during 10 months. 
2.4. Forskolin-Sepharose 
Forskolin-Sepharose was prepared from amino- 
ethyl-Sepharose CL-4B and the hydroxysuccini- 
mide ester of 7-succinyl-7-deacetylforskolin [16] or 
by condensation with 7-succinyl-7-deacetylforsko- 
lin and N-ethyl-N’-(3-dimethylaminopropyl)carbo- 
diimide in 75% dimethylformamide. Aminoethyl- 
Sepharose CL-4B was prepared as in [17] by the 
carbonyldiimidazole method. Due to the relatively 
high substitution by amino groups (20-40rmol per 
ml) chromatography of forskolin-Sepharose was 
carried out in the presence of 0.5 M NaCl to 
prevent ionic interactions. The substitution by 
7-succinyl-7-deacetylforskolin varied between 0.8 
and 2pmol per ml. 
3. RESULTS AND CONCLUSIONS 
Previous experiments from this laboratory have 
suggested that although forskolin-Sepharose does 
not retain the G-protein it may copurify with the 
catalyst provided it has been previously activated 
by GTP-analogs or NaF [16]. This is corroborated 
by the experiment in fig. 1 which compares the sedi- 
mentation behavior of two different forms in a 
sucrose density gradient. It is evident hat following 
affinity chromatography non-activated (.szo,~ = 7.0) 
and guanine nucleotide activated adenylate cyclase 
(SZO,~ = 8.7) significantly differ with respect to 
their apparent sedimentation coefficients. Since 
the forskolin is removed during gradient centrifu- 
gation the former returns to its low basal activity 
while the latter displays full activity in the absence 
of any activator. Moreover, if membranes have 
been activated with [35S]GTPyS before solubilisa- 
tion “S radioactivity exactly follows adenylate 
cyclase activity in the gradient fractions. This allows 
approximation of the turnover number of the 
nucleotide activated adenylate cyclase: Assuming a 
1: 1 stoichiometry between G-protein and catalyst, 
turnover numbers ranging from 1200 to 2000 min-’ 
could be calculated from four independent experi- 
ments. Such a value would be in good agreement 
with that estimated for the purified enzyme from 
Brevibacterium liquefaciens [26]. 
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We have purified the GTP-binding protein 
(stimulating) from duck erythrocyte membranes by 
a procedure very similar to that reported for the 
isolation of the respective proteins from liver and 
turkey erythrocyte membranes [9- 1 I]. The G-pro- 
tein is maintained in its Gpp(NH)p charged form 
throughout the purification procedure which may 
explain the excellent yield of 15-20%. Although 
activating nucleotides are supposed to reduce the 
apparent size of the G-protein due to dissociation 
of the 42 kDa/35 kDa dimer, the G-protein is iso- 
lated as a 80 kDa species as analyzed on a sucrose 
density gradient in the presence of Lubrol PX. 
Obviously, dissociation occurs only at higher dilu- 
tion. 
The G-protein can be easily radiolabeled by 
NaB3H4 via reductive methylation. More than 80% 
of the reconstitutive activity is preserved during 
this procedure. While from densitometric scans of 
Coomassie Blue stain both subunits of the G-pro- 
tein preparation appear in a 1: 1 stoichiometry, dis- 
tribution of tritium label reveals a 1:0.65 ratio in 
favor of the 42 kDa component. For reconstitution 
experiments, we have chosen the catalytic moiety 
of rabbit myocardial membranes as the acceptor 
Fig. 1. Isolation of a [35S]GTPyS-labeled adenylate 
cyclase complex from rabbit myocardial membranes. 
1.5 ml of rabbit myocardial membranes (10 mg/ml) were 
incubated with 10e7 M [35S]GTP$S (340 Ci/mmol), 
1 x 10e4 M DL-isoproterenol, 3 mM MgC12, 1 mM 
EDTA, 1 mM DTE, 10 mM Mops (pH 7.4) for 20 min at 
30°C. Following 3 washings with buffer C (5 ml each), 
solubilisation was performed in the same buffer con- 
taining 5 mM Lubrol PX at 0°C for 1 h as in [16]. For 
comparison membranes not treated with GTPyS/iso- 
proterenol were solubilized under identical conditions 
(A). 1.2 ml of the solubilized preparations were adjusted 
to SOOmM NaCl and treated with 0.3 ml of packed 
forskolin-Sepharose in buffer D under gentle shaking 
for 90min at 4°C. The mixtures were centrifuged at 
100 x g for 2 min and the supernatant removed. After 
washing the beads with buffer D (5 x 2 ml each) adeny- 
late cyclase was released by adding 1.2 ml of buffer D 
containing 1OOpM of forskolin. After gently agitating 
for 1 h at 4°C the slurry was spun down as above and 
the supernatants removed. Forskolin-Sepharose eluates 
(1.2 ml each) were concentrated in an Amicon CF 25 
filter cone device to 250~1 each and layered on top of a 
5 ml 5-20% sucrose gradient in buffer E (buffer C plus 
1 ml Tween 60) together with 3OOag LDH, 100 mg MDH 
and 5OOpg cytochrome c. Centrifugation was performed 
at 4”C, 48OOOrpm using an SW 50 rotor for 13 h. Fol- 
lowing centrifugation the gradient tubes were punctured 
and 240~1 fractions collected. Calibrating proteins were 
localized as in [3]. Adenylate cyclase activity was assayed 
in the presence (o--o) and absence (M) of 1OOpM 
forskolin. Note the absence of stimulation by forskolin 
in B (GTPyS-treated membranes). [35S]GTPyS was 
measured in 50~1 of the fractions in the presence of 
500~1 tissue soiubilizer TS-1. Numbers indicate the posi- 
tion of markers. 1, lactate dehydrogenase; 2, malate 
dehydrogenase; 3, cytochrome c. 
for the G-protein, since the homologous protein 
from duck erythrocyte membranes is only margi- 
nally activated by or bound to forskolin or 
forskolin-Sepharose, respectively. The flow dia- 
gram in fig.2 shows the reconstitution protocol 
where forskolin-Sepharose charged with catalytic 
protein is treated with and without tritiated G-pro- 
tein. Another control experiment includes incuba- 
tion of tritiated G-protein with uncharged forsko- 
lin-Sepharose: Following the reconstitution step 
and removal of non-absorbed material by washing, 
bound protein(s) are specifically released from the 
matrix by addition of free forskolin. In order to 
estimate the degree of reconstitution forskolin has 
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SOLUBILIZED ADENYLATE CYCLASE 
BIND TO FORSKOLIN -SEPHAROSE 
WASH 
INCUBATE WITH INCUBATE WITH 
BUFFER I3HI G-PROTEIN 
I \ 
1 WASH 
2 RELEASE WITH FORSKOLIN 
3 REMOVE FORSKOLIN 
BY GELFILTRATION 
/ \ 
[Cl @HlCG*Cl 
L 
Fig.2 Reconstitution of [‘H]G’I’P-binding protein with 
forskolin-Sepharose-bound catalytic moiety. Two plas- 
tic syringes (2 ml) equipped with a nylon net were sup- 
plied with 0.3ml of packed forskolin-Sepharose in 
buffer D and 1.5 ml of solubilized myocardial adenylate 
cyclase (4.5 mg) in 10 mM Mops (pH 7.4), 1 mM MgClz, 
I mM EDTA, 15 mM Lubrol PX, 500 mM NaCl (solubi- 
Iized adenylate cyclase (non-activated) prepared as in 
[16] was concectrated 3-fold in an Amicon CF-25 filter 
cone). The syringes were stoppered at both ends and 
gently shaken for 90 min at 4°C. The fluid was removed 
and the resin was washed 4 times with 2 ml each of buf- 
fer D at 4°C. One of the syringes received 300~1 of 
buffer D containing 0.2pg [3H]GTP-binding protein, 
while the other syringe received 300~1 of buffer only. 
Another control was set up by mixing 0.2pg [3H]GTP- 
binding protein in 300~1 of buffer D with the same 
amount of packed forskolin-Sepharose. The syringes 
were stoppered and shaken for 10min at 22’C and 
50min at 4°C. After removal of the fluid phase the 
resins were washed 6 times with 1.5 ml of buffer D at 
4°C. For specific release, 1 ml of buffer D containing 
1OOpM forskolin was added to the resin and the slurry 
gently shaken for 60 min at 4°C. The fluid was separated 
from the beads which were rinsed with another 400.~1 
buffer D containing 100&M forskolin. 
to be removed by gel filtration. In the non-recon- 
stituted control an adenylate cyclase [C] is obtain- 
ed which was shown functionally to be resolved 
from proteins required for guanyi nucleotide and 
fluoride activation. This adenylate cyclase is 
however stimulated by forskolin and by activated 
GTP-binding protein (table 1). On the other hand, 
if the matrix-bound catalytic subunit is reconsti- 
tuted with the purified G-protein a fully active 
adenylate cyclase preparation is obtained 
[3H][G*C]. No further activation occurs on addi- 
tion of more G-protein. If such reconstituted 
adenylate cyclase is now analyzed by SDS-poly- 
acrylamide gel electrophoresis (fig.3) only the 
radiolabeled 42 kDa component of the G-protein 
dimer is observed. When [3H]G-protein was in- 
cubated with forskolin- Sepharose not charged 
with catalytic protein much less radioactivity (3~0) 
was released. This is ascribed to nonspecific bin- 
ding, since no preference for either the 42 kDa or 
35 kDa component was observed nor was the 
Table 1 
Activities of crude (I) and forskolin-Sepharose purified 
adenylate cyclase treated with (III) and without (II) 
[3H)G-protein 
Adenylate cyclase activity 
(nmol*mg-‘. min-‘) in the 
presence of 
None G-Protein Forskolin 
Adenylate cyclase 
crude (I) 0.15 1.5 1.83 
Adenylate cyclase, 
forskolin-Sepharose 
purified (II) 83.2 620.0 610.2 
[‘HlG-Protein-reconsti- 
tuted adenylate cyclase, 
forskolin-Sepharose 
purified (III) 845.3 830.2 1110.2 
In order to remove the forskolin, 150~1 each of the 
eluates of preparations B and C were chromagotraphed 
on a small column (1 x 2.7 cm) of Sephadex G-25 fine 
equilibrated with 10 mM Mops, 1 mM MgC12, 1 mM 
EDTA, 100 mM NaCl (pH 7.4) at 4°C and 0.2 ml frac- 
tions collected. Protein-containing fractions were pooled 
(260-280~1) and 4081 aliquots assayed for adenylate 
cyclase activity in the presence and absence of 40ng of 
pure Gpp(NH)p activated G-protein or 1OOpM forsko- 
lin. The data are representative of 5 independently con- 
ducted experiments. In these experiments 70-75% of the 
applied adenylate cyclase activity (based on the reconsti- 
tutive activity with G-protein) was retained by the 
forskolin column, while 22-30% of the activity could be 
recovered following specific desorption by forskolin. 
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Fig.3. SDS-polyacrylamide g lectrophoresis of ubunits 
of the [‘H]GTP-binding protein before and after recon- 
stitution with the catalytic omponent. Purified [‘H]G- 
protein from duck erythrocyte membranes was reconsti- 
tuted with forskolin-Sepharose bound catalytic function 
(rabbit myocardium) as outlined in fig.2. Samples from 
the forskolin-Sepharose eluates were diluted 5-fold with 
buffer C (to reduce the salt) and concentrated bycentri- 
fugation in an Amicon CF25 filter cone. Samples of 
[3H]G-protein and of [3H]G-protein-reconstituted ad ny- 
late cyclase from forskolin-Sepharose were dissociated 
by addition of 200~1 of Laemmli’s ample buffer for 
12 h at room temperature and electrophoresed on 10% 
polyacrylamide rod gels as in [27]. Following electro- 
phoresis gels were cut into 2 mm slices which were subse- 
quently treated with 100111 water and 5OOpl Tissue- 
Solubilizer TS-1 for 4 h at 50°C. After cooling 10 ml of 
scintillation fluid was added for liquid scintillation 
counting. K, kDa. 
released radioactivity significantly enhanced by 
forskolin. These results strongly suggest that the 
active adenylate cyclase complex contains only the 
larger (43 kDa) subunit of the GTP-binding pro- 
tein. This feature strikingly parallels the light- 
driven GTPase of the retina where the analogous 
GTP-binding, m-component of transducin is suffi- 
cient to activate the cGMP-phosphodiesterase [28] 
and therefore adds to several other functional and 
structural homologies of these two GTP-regulated 
systems. 
While it seems reasonable that the activated 
species of adenylate cyclase represents a complex 
made up of the catalytic protein (which by itself 
may consist of several subunits) and the 42 kDa 
component of the G-protein, the situation with the 
non-activated enzyme appears to be less clear. 
Several lines of evidence suggest that the en- 
zyme purified by forskolin-Sepharose lacks the 
G-protein: 
(0 
(ii) 
It is virtually insensitive to agents acting on 
this regulatory entity, namely guanyl nucleo- 
tides, NaF and vanadate (see [16]); 
It can be reconstituted with a purified G- 
protein which becomes tightly associated as 
demonstrated by the use of radiolabeled 
G-protein (fig.3); 
(iii) Its apparent sedimentation coefficient is signi- 
ficantly smaller than that of the activated 
adenylate cyclase complex (fig. 1). 
On the other hand, the sedimentation rates of 
nonactivated and activated enzymes may not indi- 
cate differences in mass but could reflect a confor- 
mational change and consequently altered deter- 
gent binding. Moreover, the failure of ligands to 
G-protein to activate purified adenylate cyclase 
from non-activated membranes could be due to the 
absence of the 35 kDa component. The fact that 
interaction of the 42 kDa subunit of the G-protein 
and the catalyst is strong enough to resist affinity 
chromatography conditions would seem to make it 
unlikely that functional and physical reconstitu- 
tion involved an exchange between free and bound 
42 kDa subunits. Such a mechanism has been con- 
sidered recently by authors in [29] because an acti- 
vation mechanism involving dissociation/associa- 
tion of G-protein and catalyst was not compatible 
with their kinetic studies. Whether or not catalytic 
and regulatory subunits are in association/dissoci- 
ation equilibrium in solution or more important in 
their native membrane environment must await 
more detailed investigations. 
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